LOGO.png
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
November 13, 2023 16:14 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
February 14, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
August 16, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
April 15, 2021 08:07 ET | Nemaura Medical, Inc
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
March 02, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
February 11, 2021 08:45 ET | Nemaura Medical, Inc
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...